Iceland Proposes Four-Year Medical Cannabis Pilot Program

Iceland has taken a significant step towards legalizing medical cannabis with the introduction of a four-year pilot program proposal. This initiative, discussed in the Alþingi, the Icelandic Parliament, aims to authorize the use, cultivation, production, and distribution of cannabis for medical purposes. The proposal is currently awaiting approval and, if passed, will set the stage for a comprehensive regulatory framework to be developed by the Ministry of Health in collaboration with the Ministry of Culture and Commerce

Under the proposed plan, the Ministry of Health will form a working group to draft legislation that allows companies to apply for licenses to produce and distribute cannabis-based medications. The draft legislation is expected to be presented by December 31, with the pilot program slated to begin on January 1, 2024. This marks a potential shift in Iceland's current cannabis policy, which only permits the prescription of Sativex, a specific cannabis-based medication, under strict conditions

Currently, Iceland's cannabis regulations are stringent, with Sativex being the only legally prescribable cannabis-based medication. It is used to treat conditions such as multiple sclerosis and muscular dystrophy but is only available through licensed neurologists. While CBD products are allowed, they must be free of THC, the psychoactive component in cannabis. The proposed pilot program aims to expand access and knowledge of medical cannabis, drawing inspiration from Denmark's model implemented in 2018

The Danish model, which Iceland seeks to emulate, included the cultivation of cannabis for medical use and an experimental framework for understanding the medicinal properties of cannabinoids. Denmark's experience has been largely positive, providing a safe and structured environment for medical cannabis use. However, Icelandic officials acknowledge the need to review and learn from the Danish experience, addressing any shortcomings to ensure a robust program

Looking ahead, the success of this pilot program could pave the way for broader cannabis reforms in Iceland. By potentially expanding access to medical cannabis, the program aims to address chronic pain management and reduce illegal cannabis use. The proposal reflects a growing recognition of the medical benefits of cannabis, despite ongoing debates about its efficacy and safety. As Iceland awaits the Alþingi's decision, stakeholders are hopeful for a progressive shift in the nation's approach to cannabis legislation